Maravai Lifesciences Holdings Inc (MRVI) — Financial Flexibility Index
Maravai Lifesciences Holdings Inc (MRVI) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-12.22 Million (operating CF $-15.15 Million minus capex $2.93 Million) represents 0% of total liabilities ($417.33 Million). Also explore MRVI shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Maravai Lifesciences Holdings Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Maravai Lifesciences Holdings Inc across 7 annual periods. Check how strategically is Maravai Lifesciences Holdings Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Maravai Lifesciences Holdings Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Maravai Lifesciences Holdings Inc. For the full company profile including market capitalisation, see MRVI stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.09x | $37.12 Million | $7.46 Million | $431.04 Million | ▼ -68.7% |
| 2023 | 0.27x | $191.78 Million | $126.22 Million | $697.57 Million | ▼ -31.5% |
| 2022 | 0.40x | $553.07 Million | $535.98 Million | $1.38 Billion | ▲ +43.8% |
| 2021 | 0.28x | $383.42 Million | $368.57 Million | $1.37 Billion | ▲ +75.5% |
| 2020 | 0.16x | $177.59 Million | $152.19 Million | $1.12 Billion | ▲ +67.1% |
| 2019 | 0.10x | $41.26 Million | $24.11 Million | $433.17 Million | ▲ +989.3% |
| 2018 | 0.01x | $3.42 Million | $-186.00K | $391.66 Million | — |